Holistic artificial intelligence-driven predictor in HER2-positive (HER2+) early breast cancer (BC) treated with neoadjuvant lapatinib and trastuzumab without chemotherapy: A correlative analysis from SOLTI-1114 PAMELA

Autor:	Batistella E, Pare L, Sahasrabudhe M, Pascual T, Vakalopoulou M, Villagrasa P, Deutsch E, Chic N, Villacampa G, Nuciforo P, Cortes J, Llombart-Cussac A, Paragios N, Prat A
Rok vydání:	2021
Zdroj:	CANCER RESEARCH r-FISABIO. Repositorio Institucional de Producción Científica instname
ISSN:	0008-5472
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c6ae2a659fb3e0289140021b31517fa6 https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12647 Zobrazit plný text záznamu